Medico Remedies Limited has issued a notice regarding an upcoming meeting of the Board of Directors. The meeting is scheduled to be held on Monday, 9th November 2026.
The primary agenda items for the board meeting include:
- Consideration and approval of the Unaudited Financial Results for the quarter ended 30th September, 2026
- Consideration and approval of the Limited Review Report on the financial results
- Any other business with the permission of the Chair
The disclosure was signed by Haresh Kapurlal Mehta, Chairman & Whole-time Director (DIN: 01080289), on 3rd November 2026 at 17:39:10 IST. The notice was addressed to both BSE Limited and the National Stock Exchange of India Limited as part of regulatory compliance requirements.
Financial Impact
Financial results for the quarter ended September 30, 2026 are pending board approval. Actual financial figures and impact will be disclosed following the board meeting.